Literature DB >> 16823935

Preparation and evaluation of vibrio cholerae O1 EL Tor Ogawa lipopolysaccharide-tetanus toxoid conjugates.

Osmir Cabrera1, Miguel E Martínez, Maribel Cuello, Carmen R Soto, Tania Valmaseda, Bárbara Cedré, Gustavo Sierra González.   

Abstract

The lipopolysaccharide (LPS) of Vibrio cholerae is considered one of the most important antigens from the point of view of immunogenicity in these bacteria. We have undertaken detoxification of this LPS by basic hydrolysis and the resultant amine groups were used for their conjugation to tetanus toxoid as carrier protein using carbodiimide-mediated coupling. The resulting conjugates were inoculated in Balb/c mice for immunogenicity studies. The anti-LPS IgG and vibriocidal antibodies were measured in serum. The antigenicity of this conjugated was evaluated by ELISA, with serums of humans vaccinated with a strain genetically modified. The conjugated elicited: high titers of IgG anti-LPS, high titers of vibriocidal antibodies and there was recognition of LPS by antibodies from cholerae immunised human serum. These results show that the conjugated LPS obtained by us, could be evaluated like a potential vaccine for human use.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16823935     DOI: 10.1016/j.vaccine.2005.01.130

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.

Authors:  Stefan Schild; Eric J Nelson; Andrew Camilli
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

2.  Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen.

Authors:  Deborah R Leitner; Sandra Feichter; Kristina Schild-Prüfert; Gerald N Rechberger; Joachim Reidl; Stefan Schild
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

3.  Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba.

Authors:  Cyrille Grandjean; Alain Boutonnier; Bruno Dassy; Jean-Michel Fournier; Laurence A Mulard
Journal:  Glycoconj J       Date:  2008-07-23       Impact factor: 2.916

Review 4.  Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected).

Authors:  Patricia M Graves; Jonathan J Deeks; Vittorio Demicheli; Tom Jefferson
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

5.  Preparation and Evaluation of a New Lipopolysaccharide-based Conjugate as a Vaccine Candidate for Brucellosis.

Authors:  Seyed Davar Siadat; Farzam Vaziri; Mamak Eftekhary; Maryam Karbasian; Arfa Moshiri; Mohammad R Aghasadeghi; Mehdi S Ardestani; Meghdad Abdollahpour Alitappeh; Amin Arsang; Abolfazl Fateh; Shahin Najar Peerayeh; Ahmad R Bahrmand
Journal:  Osong Public Health Res Perspect       Date:  2014-12-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.